CGEN
Compugen
2.40$
+1.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 6.0% | 82.1% | 23.2% | 21.0% | 45.9% | 105.1% | 132.5% | 87.3% | 5.3% | 83.8% | 103.5% | 13.1% | |
| – | 94.0% | 17.9% | 76.8% | 79.0% | 54.1% | -5.1% | -32.5% | 12.7% | 94.7% | 16.2% | -3.5% | 86.9% | |
| – | 32.7% | 250.5% | 92.3% | 36.8% | 401.8% | 252.8% | 448.8% | 306.7% | 8.2% | 318.8% | 242.4% | 33.2% | |
| – | 7.4% | 95.7% | 33.2% | 15.0% | 149.6% | 103.6% | 178.1% | 116.1% | 3.1% | 105.6% | 86.8% | 11.9% | |
| – | 40.3% | 349.7% | 127.8% | 52.7% | 562.8% | 362.5% | 638.1% | 430.1% | 11.5% | 430.6% | 336.1% | 45.9% | |
| – | 53.7% | -331.8% | -50.9% | 26.2% | -508.7% | -367.6% | -670.6% | -417.4% | 83.2% | -414.4% | -339.6% | 40.9% | |
| – | 0.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 55.9% | -283.9% | -31.5% | 33.7% | -415.6% | -313.0% | -585.4% | -366.9% | 84.4% | -352.2% | -269.0% | 47.6% | |
| – | 26.9% | 0.1% | 0.2% | 26.3% | 0.3% | 1.4% | -1.4% | 2.1% | – | 0.2% | 0.3% | – | |
| – | 29.0% | -284.0% | -31.7% | 7.4% | -415.8% | -314.4% | -584.1% | -369.1% | 84.4% | -352.4% | -269.3% | 47.6% | |
| – | 56.1% | -283.9% | -31.5% | 33.7% | -415.6% | -313.0% | -585.4% | -366.9% | 84.4% | -352.2% | -269.0% | 47.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.